Internal Medicine, Medical Oncology · Houston, TX
NPI
1649441601
Since 2008
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
925 Gessner Rd Ste 600
Houston, TX, 77024
Phone (713) 827-9525
Groups this clinician bills Medicare through
Medicare paid, 2024
$297K
10,837 services
Medicare patients, 2024
56
Average age 76
Drug cost, 2024
$2.4M
964 prescriptions
Company payments, 2025
$150K
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ricardo H Alvarez was code 85025 (blood count), 90 times for 42 patients. In total Ricardo H Alvarez billed 10,837 services in 47 codes, and Medicare paid $297K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 85025 Blood Count | Office | 90 | 42 | $7.54 | $678 |
| 99214 Office E&M - Established | Office | 57 | 34 | $87.54 | $4,990 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 52 | 33 | $12.87 | $669 |
| 99215 Office E&M - Established | Office | 35 | 27 | $137.69 | $4,819 |
| 99205 Office E&M - New | Office | 12 | 12 | $152.48 | $1,830 |
By year: 2022 $430K for 10,372 services; 2023 $550K for 26,276 services; 2024 $297K for 10,837 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 90 | 42 | $7.54 | $678 |
Medicare prescription drug claims, 2024
In 2024, the drug Ricardo H Alvarez prescribed most often to Medicare patients was Anastrozole, with 80 prescriptions and refills. In total Ricardo H Alvarez wrote 964 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 80 | 225 | 28 | $1,574 |
| Alendronate Sodium Generic | 60 | 141 | 23 | $559 |
| Erleada Apalutamide | 48 | 48 | Under 11 | $683K |
| Dexamethasone Generic | 46 | 51 | 21 | $800 |
| Olanzapine Generic | 39 | 42 | 17 | $222 |
| Gabapentin Generic | 34 | 52 | 12 | $268 |
| Letrozole Generic | 29 | 79 | Under 11 | $769 |
| Ondansetron Odt Ondansetron | 28 | 28 | 17 | $531 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 28 | 28 | 21 | $327 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 26 | 26 | 15 | $475 |
| Loperamide Loperamide Hcl | 22 | 22 | 16 | $262 |
| Aprepitant Generic | 22 | 22 | Under 11 | $8,172 |
| Tramadol Hcl Generic | 19 | 19 | 11 | $113 |
| Granisetron Hcl Generic | 18 | 18 | 16 | $9,909 |
| Tamoxifen Citrate Generic | 18 | 52 | Under 11 | $825 |
Brand drugs: 194 claims; generic drugs: 770 claims; opioid claims: 72.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ricardo H Alvarez $150K ($150K in general payments such as food, travel and fees) from 33 companies. The largest payer was Gilead Sciences, Inc. with $75K.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 56 | $75K |
| Stemline Therapeutics Inc. | 28 | $30K |
| Daiichi Sankyo Inc. 4568.T | 24 | $24K |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $18K |
| Novartis Pharmaceuticals Corporation NVS | 10 | $2,072 |
| Pfizer Inc. PFE | 5 | $98.82 |
| Tempus AI, Inc TEM | 5 | $93.54 |
| Janssen Biotech, Inc. JNJ | 4 | $82.29 |
| GlaxoSmithKline, LLC. GSK | 3 | $81.37 |
| PharmaEssentia USA Corporation 6446.TW | 3 | $70.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.